Laborie Medical Technologies Expands Maternity Care with JADA® System Acquisition

Laborie's Strategic Acquisition of JADA® System for Maternal Health

Laborie Medical Technologies Corp, a prominent player in medical technologies, has achieved a significant milestone with its recent acquisition of the JADA® System. This innovative device is designed for the rapid control and treatment of abnormal postpartum uterine bleeding, marking an important addition to Laborie’s obstetrics portfolio.

Laborie has long been committed to enhancing maternal and neonatal healthcare, and this acquisition represents a bold step in addressing the rising concerns regarding postpartum hemorrhage (PPH), the leading cause of maternal mortality worldwide. According to data from the World Health Organization, PPH contributes to over 20% of maternal deaths globally, leading to millions of women experiencing severe complications during one of the most critical times of their lives: childbirth.

The JADA System is notable for its FDA-approved mechanism, which uses low-level vacuum technology to stimulate natural uterine contractions, thereby rapidly halting bleeding. This innovative approach has already benefited over 136,000 mothers across more than 20 countries, further establishing vacuum-induced postpartum hemorrhage care as a recognized standard of practice.

Nikki Bruce, Laborie's Vice President and General Manager of OB, emphasizes the importance of this technology, stating, "The JADA System helps care teams provide treatment during one of the most vulnerable moments of childbirth when every second counts." This statement resonates powerfully in the context of maternal health, highlighting how each second can affect outcomes for both mothers and newborns.

As Laborie integrates the JADA System into its array of obstetric solutions—covering antepartum, intrapartum, postpartum, neonatal, and surgical care—it further strengthens its mission to ensure that every mother and child leaves the hospital in good health. Laborie CEO Chris Smith remarked, "The addition of the JADA System marks a tremendous milestone for our OB unit and an exciting chapter in Laborie's history." This reflects the company’s ongoing commitment to elevating the standard of care for clinicians and patients alike.

The acquisition also leads to the inclusion of over 90 new team members, primarily focusing on commercial roles, which will enhance Laborie’s operational capacity.

Laborie’s acquisition is supported by extensive clinical research that attests to the safety and effectiveness of the JADA system. Clinical studies, including findings published in reputable medical journals, validate its role in quickly addressing postpartum complications, which could potentially save lives and improve outcomes in delivery rooms worldwide.

Adding to Laborie’s portfolio of technologies aimed at improving maternal health outcomes globally, the JADA System offers a proven, innovative solution that is vital for caregivers and mothers alike. Sofia Gerard, Managing Director at Patricia Industries (the investment partner of Laborie), stated, "This addition highlights Laborie's dedication to improving maternal health outcomes globally and brings a proven, innovative option that complements our portfolio."

Laborie Medical Technologies continues to position itself as a leader in the medical technology landscape, bolstered by partnerships that focus on sustainable growth and innovation. As progress in maternal healthcare becomes more urgent, Laborie's initiatives signify a proactive response to a critical need, ultimately aiming to reduce maternal mortality rates and enhance the overall birthing experience.

For further details on the JADA® System and its applications in maternal health, visit Laborie's official website at www.laborie.com.

About Laborie Medical Technologies

Founded and headquartered in Portsmouth, New Hampshire, Laborie is a global medical technology company that specializes in Urology, Urogynecology, Gastroenterology, Obstetrics, Gynecology, and Neonatal Health. Laborie is recognized for its high-quality diagnostic and therapeutic products, supporting clinicians and hospitals with world-class clinical education and information programs. The company is part of Patricia Industries, a long-term investment entity focused on enhancing technological innovations for patient care.